GPP
YARW

Great Point Partners’s Yarrow Bioscience YARW Stock Holding History

Great Point Partners’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-459
Closed -$4.43M – 41
2020
Q1 		$4.43M Hold
459
– – 0.46% 31
2019
Q4 		$7.67M Hold
459
– – 0.67% 27
2019
Q3 		$7.4M Sell
459
-23
-5% -$371K 0.68% 32
2019
Q2 		$10.4M Sell
482
-89
-16% -$2.2M 1.15% 21
2019
Q1 		$16.1M Sell
571
-41
-7% -$984K 1.6% 22
2018
Q4 		$9.08M Buy
612
+250
+69% +$5.6M 1.15% 29
2018
Q3 		$12.8M Buy
+362
New +$11.2M 2% 19
2018
Q2 		– Sell
-14
Closed -$1.95M – 45
2018
Q1 		$1.95M Buy
+14
New +$1.7M 0.29% 31

Other funds holding YARW

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Great Point Partners's YARW Position: Q2 2020 in Review

Great Point Partners sold out of Yarrow Bioscience (YARW) in Q2 2020, closing a stake of 459 shares — an estimated $4.43M sold.

Great Point Partners first reported a position in YARW in Q1 2018 and held it in 8 quarters. The position peaked at $16.1M in Q1 2019. 98 funds tracked by Wall St. Rank hold YARW as of Q2 2020.

  • Great Point Partners reported no remaining Yarrow Bioscience position as of Q2 2020 after selling out during the quarter.
  • Great Point Partners sold 459 Yarrow Bioscience shares in Q2 2020, an estimated $4.43M.
  • Great Point Partners first reported a position in Yarrow Bioscience in Q1 2018 and held it in 8 quarters.
  • Great Point Partners's Yarrow Bioscience position peaked at $16.1M in Q1 2019.
  • 98 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2020.

Based on Great Point Partners's 13F filing for Q2 2020, filed 14 Aug 2020.